Lilly’s new GLP-1 pill is off to a ‘robust’ start

lilly's new glp-1 pill had 1,390 prescriptions in its first week on the market. the company described the launch as "robust." the oral drug, zepbound, is a competitor to injectable weight-loss treatments like wegovy.